Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Perspective Therapeutics (CATX) Times Interest Earned (2016 - 2025)

Perspective Therapeutics (CATX) has disclosed Times Interest Earned for 10 consecutive years, with -$622.38 as the latest value for Q4 2025.

  • Quarterly Times Interest Earned fell 201.0% to -$622.38 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$302.03 through Dec 2025, up 84.05% year-over-year, with the annual reading at -$302.03 for FY2025, 84.05% up from the prior year.
  • Times Interest Earned hit -$622.38 in Q4 2025 for Perspective Therapeutics, down from -$428.63 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of $616.22 in Q4 2024 to a low of -$696.43 in Q3 2023.
  • Historically, Times Interest Earned has averaged -$353.86 across 3 years, with a median of -$438.54 in 2024.
  • Biggest five-year swings in Times Interest Earned: skyrocketed 226.66% in 2024 and later crashed 201.0% in 2025.
  • Year by year, Times Interest Earned stood at -$486.5 in 2023, then surged by 226.66% to $616.22 in 2024, then plummeted by 201.0% to -$622.38 in 2025.
  • Business Quant data shows Times Interest Earned for CATX at -$622.38 in Q4 2025, -$428.63 in Q3 2025, and -$202.01 in Q2 2025.